Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Lymphoma, Non-Hodgkin, Date of authorisation: 10/05/2012, Revision: 19, Status: Authorised

2019 Case Medical Research  
doi:10.31525/cmr-cdebc9 fatcat:a34l2xzlznb65o4xiv2totzdmq